| 存储条件 |
|---|
| Product Name | CYCS |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CYC; HCS; THC4 |
| Immunogen | Purified recombinant fragment of human CYCS (AA: 1-105) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. | |
| Species Reactivity | HumanMouse |
| Alternative Names | CYC HCS THC4 |
|---|---|
| Molecular Weight(MW) | 11.7kDa |
| Entrez Gene | 54205 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using CYCS mAb against human CYCS (AA: 1-105) recombinant protein. (Expected MW is 41.6 kDa)
Application
Figure 3:Western blot analysis using CYCS mAb against HEK293 (1) and CYCS (AA: 1-105)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Western blot analysis using CYCS mouse mAb against Hela (1), Jurkat (2), RAW264.7 (3), NIH/3T3 (4), HL-60 (5), K562 (6), HepG2 (7), and MCF-7 (8) cell lysate.
Application
Figure 5:Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using CYCS mouse mAb with DAB staining.
Application
Figure 6:Immunohistochemical analysis of paraffin-embedded stomach cancer tissues using CYCS mouse mAb with DAB staining.
Application
Figure 7:Flow cytometric analysis of Hela cells using CYCS mouse mAb (green) and negative control (red).| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
抱歉，暂无相关文献
